Portland, OR -- (SBWIRE) -- 05/24/2018 -- Global single-use bioprocessing material market was valued at $2,800.0 million in 2016 and is expected to reach $9,342.1 million by 2023 supported by a CAGR of 18.7% during the forecast period 2017 to 2023. Advancements in the materials incorporated in the construction of single-use bioprocessing products has played a pivotal role in boosting the demand for single-use bioprocessing (SUB) products across the globe.

Increasing preference for use of high-grade polymer materials in the construction of single-use bioprocessing products have fueled the market growth. In addition, development of advanced materials that can offer integral strength to the single-use bioprocessing products is expected to supplement the market growth. Conversely, existing concerns regarding the large-scale disposal of plastic derivatives used in the SUB products is expected to hamper the market growth. Moreover, increase in the incorporation of cost-effective materials in the development of single-use bioprocessing products is anticipated to offer lucrative opportunities for the market expansion.

Product segment review

Global single-use bioprocessing material market by product is classified into three segments namely plastic, silicone, and other. The plastic material is further categorized into polyethylene, polyvinyl chloride, polyamide, and other plastic materials. Plastics accounted for the highest share in the total single-use bioprocessing material market by material in 2016, and this trend is expected to remain the same throughout the forecast period. This is attributed to features of plastics such as low cost, ease of manufacture, versatility, and resistant to the damage caused by water. In addition, large scale employment of plastic materials in the construction of multiple single-use bioprocessing products, including media bags, bioprocess containers, tangential-flow filtration devices, mixing systems, and sampling systems has contributed to the robust growth displayed by this segment from 2017-2023.

End User segment review

On the basis of end user, the single-use bioprocessing material market is fragmented into biopharmaceutical manufacturers, life science R&D and academic research institutes, and contract research organization & manufacturers. Biopharmaceutical manufacturers have dominated the single-use bioprocessing material market in 2016 and is anticipated to maintain this dominance throughout the forecast period. Single-use bioprocessing products have gained rapid acceptance by biopharmaceutical manufacturers worldwide in recently and is anticipated to do so in future. This is due to the adoption of single-use bioprocessing products by biopharmaceutical manufacturers that has reduced overall contamination rates, enhanced production throughput efficiency, and has further decreased maintenance costs. Whereas, contract research organization & manufacturers segment is expected to grow at the fastest pace during the forecast period. Contract research organizations (CROs) and manufacturers (CMOs) are expected to be the promising end users of the single-use bioprocessing market as the demand for single-use bioprocessing products in these sectors is rising at a significant pace.

Do purchase inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/4600

Regionally, the single-use bioprocessing material market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the global single-use bioprocessing material market followed by Europe and Asia-Pacific. The dominance of North America region in the single-use bioprocessing material market is primarily attributed to the on-going trend of introducing novel single-use bioprocessing devices in developed economies such as the U.S. and Canada and then unveiling it to the rest of the world. Whereas, Asia-Pacific region is anticipated to grow at the fastest rate from 2017-2023, and strong growth in both the pharma and laboratory equipment industry witnessed in this region has contributed to its robust growth.

The report provides a comprehensive analysis of the key players operating in the global single-use bioprocessing material market such as Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd. The other companies profiled in this report include Octane Biotech Inc., PBS Biotech, Inc., Meissner Filtration Products, Inc., Sentinel Process Systems Inc., CMC Biologics (Asahi Glass Co.), Novasep, PendoTECH, and BioPure Technology Ltd.